Novamechanics

Novamechanics Ltd is an in silico drug design company committed to the computer aided design of small molecules for a very wide range of target classes. The company is focused on the development and implementation of in silico methods to guide decisions in the design and selection of promising drug candidates. Through the combination of industry-recognized expertise, state of the art software and proprietary computing infrastructure, the company's advanced in silico capabilities in molecular design and simulation provide the most effective path to drug innovation. Our mission is to help to bridge the gap between disease targets and optimal quality drug candidates with significantly lower costs and increased potential revenues for our collaborators. NovaMechanics Ltd provides: 1. Bespoke in silico drug design and discovery products and services centred on high throughput computational techniques. 2. Algorithms can rapidly convert ligand information or protein structure information into new chemical designs, maximising the value within the research portfolio of a pharmaceutical partner. 3. Combines expert modelling and first class synthetic chemistry knowledge to ensure that projects are chemistry driven whilst maximising CADD technology. Furthermore the research team has experience in a range of CADD techniques from protein and ligand modelling, structure based design methods, chemoinformatics for data management, ADMET and PBPK models.